Medical Technology

Code of Conduct for Cancer Immunologists “Seriously Bleached” research

According to his former employer an immunologist with cancer who was ” the most cited immunologist in Australia” in 2017 has “seriously violated the Codes of conduct relating to responsible research conduct.”

QIMR Berghofer, Brisbane, “has ordered an independent external investigation after several complaints relating to the research conduct by a former employee Professor Mark Smyth,” according to .

The external investigation, led by a retired judge of the appeals court, Robert Gotterson, followed an initial investigation according to QIMR Berghofer, which said it “has referred the findings to the Crime and Corruption Commission in compliance with its legal obligations.” The institute has “also organized for an independent review into a broad range of issues arising from the Panel Report” that will be led by former federal court judge Bruce Lander.

The statement does not provide details of the specifics of what Smyth did to violate the research code.

Smyth quit from QIMR Berghofer in August of this year. Fabienne Mackay (director and chief executive officer of the institution) stated that Smyth had been leading an “large important research program” for more than eight years, and had “strongly promoted many of the early career scientists.”

The immunologist was awarded what we called a megacorrection in 2015 and a retract in the year 2006.

In 2017 Smyth was elected to the Australian Academy of Science . In the year 2020, he was appointed to the advisory board of scientists of Shanghai-based EpimAb Biotherapeutics.

He was not available for comment immediately.

Content Source:

The Medical Progress

The Medical Progress is here to provide news for the medical industry on a daily basis which are mainly on the medical cannabis and it’s legalisation.

Related Articles